Targeted activation of AMPK by GSK621 ameliorates H2O2-induced damages in osteoblasts.

Oncotarget

Department of Orthopedics, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, China.

Published: February 2017

GSK621 is a novel AMP-activated protein kinase (AMPK) activator. This study tested its potential cytoprotective effect in hydrogen peroxide (H2O2)-treated osteoblasts. In cultured MC3T3-E1 osteoblastic cells and primary murine osteoblasts, GSK621 significantly attenuated H2O2-induced cell death and apoptosis. AMPK activation was required for GSK621-induced osteoblast cytoprotection. Inhibition of AMPK, by AMPKα1 T172A mutation or shRNA silence, almost completely blocked GSK621-induced osteoblast cytoprotection. Reversely, introduction of a constitutively-active AMPKα1 (T172D) alleviated H2O2 injuries in MC3T3-E1 cells. Further, GSK621 increased nicotinamide adenine dinucleotide phosphate (NADPH) content in osteoblasts to inhibit H2O2-induced reactive oxygen species (ROS) production. Meanwhile, GSK621 activated cytoprotective autophagy in the osteoblasts. On the other hand, pharmacological inhibition of autophagy alleviated GSK621-mediated osteoblast cytoprotection against H2O2. These results suggest that targeted activation of AMPK by GSK621 ameliorates H2O2-induced osteoblast cell injuries.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354679PMC
http://dx.doi.org/10.18632/oncotarget.14454DOI Listing

Publication Analysis

Top Keywords

osteoblast cytoprotection
12
targeted activation
8
activation ampk
8
ampk gsk621
8
gsk621 ameliorates
8
ameliorates h2o2-induced
8
osteoblasts gsk621
8
gsk621-induced osteoblast
8
gsk621
6
ampk
5

Similar Publications

Exploring the Osteoinductive Potential of Bacterial Pyomelanin Derived from in a Human Osteoblast Model.

Int J Mol Sci

December 2024

Department of Immunology and Infectious Biology, Faculty of Biology and Environmental Protection, University of Lodz, 12/16 Banacha St, 90-237 Łódź, Poland.

Alkaptonuria (AKU) is a genetically determined disease associated with disorders of tyrosine metabolism. In AKU, the deposition of homogentisic acid polymers contributes to the pathological ossification of cartilage tissue. The controlled use of biomimetics similar to deposits observed in cartilage during AKU potentially may serve the development of new bone regeneration therapy based on the activation of osteoblasts.

View Article and Find Full Text PDF

Cadmium (Cd) and lead (Pb) are heavy metals (HMs) that persistently contaminate the ecosystem, and bioaccumulation in bones is a health concern. We used biochemical and molecular assays to assess the cytoprotective effect of vitamin D (VD) on Cd- and Pd-induced chemical toxicity of human bone osteoblasts in vitro. Exposing Cd and Pb to human osteoblast cultures at concentrations of 0.

View Article and Find Full Text PDF

Cytoprotective Effect of Gallic Acid against Injuries Promoted by Therapeutic Ionizing Radiation in Preosteoblast Cells.

Int J Mol Cell Med

January 2024

Laboratory of Health Science, Postgraduate Program in Health Sciences, Universidade Estadual de Montes Claros, Minas Gerais, Brazil.

Gallic acid (GA) is a powerful antioxidant extracted from plants of the Brazilian Cerrado. Oxidative stress plays an important role in the occurrence of radiation-induced osteonecrosis in patients treated for head and neck cancer. There is a need to develop research aimed at developing complementary therapies to prevent or reverse bone damage.

View Article and Find Full Text PDF

Though crucial for natural bone healing, local calcium ion (Ca) and phosphate ion (P) concentrations can exceed the cytotoxic limit leading to mitochondrial overload, oxidative stress, and cell death. For bone tissue engineering applications, HS can be employed as a cytoprotective molecule to enhance mesenchymal stem cell (MSC) tolerance to cytotoxic Ca/P concentrations. Varied concentrations of sodium hydrogen sulfide (NaSH), a fast-releasing HS donor, were applied to assess the influence of HS on MSC proliferation.

View Article and Find Full Text PDF

Melatonin as a chronobiotic/cytoprotective agent in bone. Doses involved.

J Pineal Res

January 2024

CENECON, Faculty of Medical Sciences, Universidad de Buenos Aires, Buenos Aires, Argentina.

Because the chronobiotic and cytoprotective molecule melatonin diminishes with age, its involvement in postmenopausal and senescence pathology has been considered since long. One relevant melatonin target site in aging individuals is bone where melatonin chronobiotic effects mediated by MT1 and MT2 receptors are demonstrable. Precursors of bone cells located in bone marrow are exposed to high quantities of melatonin and the possibility arises that melatonin acts a cytoprotective compound via an autacoid effect.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!